31 research outputs found
Anxiety affects the amplitudes of red and green colorelicited flash visual evoked potentials in humans
It has been reported that negative emotional changes and conditions affect the
visual faculties of humans at the neural level. On the other hand, the effects of emotion
on color perception in particular, which are based on evoked potentials, are unknown. In
the present study, we investigated whether different anxiety levels affect the color information processing for each of 3 wavelengths by using flash visual evoked potentials (FVEPs) and State-Trait Anxiety Inventory. In results, significant positive correlations were observed between FVEP amplitudes and state or trait anxiety scores in the long (sensed as red) and middle (sensed as green) wavelengths. On the other hand, short-wavelength-evoked FVEPs were not correlated with anxiety level. Our results suggest that negative emotional conditions may affect color sense processing in humans
Small-parallel exemplar-based voice conversion in noisy environments using affine non-negative matrix factorization
A novel treatment based on powder jet deposition technique for dentin hypersensitivity: a randomized controlled trial
Abstract Background This study aimed to evaluate the efficacy and safety of dentin hypersensitivity (DH) treatment using a newly developed device based on a powder jet deposition (PJD) technique that creates a hydroxyapatite (HAP) layer on the dentin surface, thereby alleviating the hypersensitivity. The effect of the PJD treatment was compared with that of conventional treatment using Teethmate Desensitizer (TMD; calcium-phosphate containing material with TTCP (Ca4(PO4)2O) and DCPA (CaHPO4)), which has been used clinically in Japan with well-confirmed effectiveness. Materials and methods A randomized controlled trial was conducted including 35 patients who had symptoms of DH in two or more quadrants. Two test teeth were selected per patient (70 teeth in total) and randomly assigned to PJD or TMD treatment. The efficacy was evaluated using the improvement rate for air and scratch pain according to the scores obtained via visual analog scale 12 weeks after treatment. The safety assessment was performed focusing on gingival index (GI) and spontaneous pain. The t-test was used to analyze the non-inferiority of PJD treatment compared to TMD treatment. Results The improvement rate of air pain was 69.0% for PJD and 69.7% for TMD. The improvement rate of scratch pain was 80.8% for PJD and 81.7% for TMD. Non-inferiority with a margin of 10% was not observed for both air and scratch pain. No change was observed in GI from baseline and the improvement rate of spontaneous pain for PJD was higher than that for TMD. Conclusion Non-inferiority of PJD to TMD treatment was not observed in this study; however, it was not statistically demonstrated, and the results were thus interpreted as inconclusive. PJD did improve the DH symptoms, as did TMD. PJDās therapeutic effect was most likely attributable to the deposition of a HAP layer on the tooth surface, which would alleviate hypersensitivity for at least 12 weeks without causing severe adverse events. Trial registration UMIN-CTR. ID: UMIN000025022. date: 02/12/2016
Response of tree growth and wood structure of Larix kaempferi, Kalopanax septemlobus and Betula platyphylla saplings to elevated CO2 concentration for 5 years exposure in a FACE system
Elevated CO (2) concentration affected biomass partitioning in above-ground biomass, but size and number of water-conducting cells were unchanged in Larix kaempferi, Kalopanax septemlobus and Betula platyphylla. Using a Free-Air CO2 Enrichment (FACE) system, we studied the effect of elevated CO2 on the growth, leaf gas exchange and xylem anatomy of a conifer, Larix kaempferi, and two angiospermous tree species, Kalopanax septemlobus and Betula platyphylla. Two-year-old seedlings were grown at control sites (ambient; 370 ppm) and FACE sites (elevated; 500 ppm) for 5 years. We measured the lumen area and number of water-conducting cells, as well as biomass and leaf gas exchange, and visualized the functional region of water transport using a dye injection experiment. Elevated CO2 did not induce any significant changes in growth or in leaf gas exchange or lumen area of earlywood tracheids in L. kaempferi relative to ambient CO2. In two other tree species, elevated CO2 was found to enhance tree height and total leaf area (LA), with no change in stomatal conductance. In K. septemlobus, there were no changes in lumen area or number of earlywood vessels, or in the functional region of water transport. B. platyphylla also underwent no changes in lumen area or number of vessels, although there was a yearly variation in the size of the vessels. Our results show that 5 years of CO2 exposure did not notably affect the anatomical features of water-conducting cells. This finding suggests that, under elevated CO2, trees respond to changes in water balance due to changes in LA by extending the hydraulically active area of xylem
Molecular diversity of tuliposide B-converting enzyme in tulip (<i>Tulipa gesneriana</i>): identification of the third isozyme with a distinct expression profile
<p>6-Tuliposide B (PosB), a major secondary metabolite that accumulates in tulip (<i>Tulipa gesneriana</i>), is converted to the antibacterial lactone, tulipalin B (PaB), by PosB-converting enzyme (TCEB). <i>TgTCEB1</i> and <i>TgTCEB-R</i>, which encode TCEB, are specifically expressed in tulip pollen and roots, respectively, but are hardly expressed in other tissues (e.g. leaves) despite the presence of substantial PosB-converting activity, suggesting the existence of another TCEB isozyme. Here, we describe the identification of <i>TgTCEB-L</i> (āLā for leaf), a paralog of <i>TgTCEB1</i> and <i>TgTCEB-R</i>, from leaves via native enzyme purification. The enzymatic characters of TgTCEB-L, including catalytic activity and subcellular localization, were substantially the same as those of TgTCEB1 and TgTCEB-R. However, <i>TgTCEB-L</i> did not exhibit tissue-specific expression. Identification of <i>TgTCEB-L</i> explains the PosB-converting activity detected in tissues where <i>TgTCEB1</i> and <i>TgTCEB-R</i> transcripts could not be detected, indicating that tulip subtilizes the three TgTCEB isozymes depending on the tissue.</p> <p>Three isozymes are involved in the conversion of 6-tuliposide B, a major secondary metabolite in tulip, to antibacterial tulipalin B.</p
A New BoronāRhodamine-Containing Carboxylic Acid as a Sugar Chemosensor
We propose a boronārhodamine-containing carboxylic acid (BRhoC) substance as a new sugar chemosensor. BRhoC was obtained by the FriedelāCrafts reaction of 4-formylbenzoic acid and N,N-dimethylphenylboronic acid, followed by chloranil oxidation. In an aqueous buffer solution at pH 7.4, BRhoC exhibited an absorption maximum (Absmax) at 621 nm. Its molar absorption coefficient at Absmax was calculated to be 1.4 Ć 105 Mā1 cmā1, and it exhibited an emission maximum (Emmax) at 644 nm for the excitation at 621 nm. The quantum yield of BRhoC in CH3OH was calculated to be 0.16. The borinate group of BRhoC reacted with a diol moiety of sugar to form a cyclic ester, which induced a change in the absorbance and fluorescence spectra. An increase in the D-fructose (Fru) concentration resulted in the red shift of the Absmax (621 nm without sugar and 637 nm with 100 mM Fru) and Emmax (644 nm without sugar and 658 nm with 100 mM Fru) peaks. From the curve fitting of the plots of the fluorescence intensity ratio at 644 nm and 658 nm, the binding constants (K) were determined to be 2.3 Ć 102 Mā1 and 3.1 Mā1 for Fru and D-glucose, respectively. The sugar-binding ability and presence of a carboxyl group render BRhoC a suitable building block for the fabrication of highly advanced chemosensors
Ecophysiology of deciduous trees native to Northeast Asia grown under FACE (Free Air CO<sub>2</sub> Enrichment)
Blood Lactate Functions as a Signal for Enhancing Fatty Acid Metabolism during Exercise via TGF-Ī² in the Brain
Moderate-intensity running (treadmill velocity of 21 m/min) increased blood lactate and actived transforming growth factor-Ī² (TGF-Ī²) concentration in rat cerebrospinal fluid (CSF). On the other hand, low-intensity running (15 m/min) did not increase blood lactate and caused no change in CSF TGF-Ī². Intraperitoneal (i.p.) administration of lactate to anesthetized rats caused an increase in blood lactate similar to that observed after a 21 m/min running exercise and increased the level of active TGF-Ī² in CSF. Intraperitoneal administration of lactate at the same dose to awake and unrestricted rats caused a decrease in the respiratory exchange ratio, that is, enhancement of fatty acid oxidation and depression of spontaneous motor activity (SMA). Given that intracisternal administration of TGF-Ī² to rats has been reported to enhance fatty acid metabolism and to depress SMA, we surmise that the observed changes caused by i.p. lactate administration in this study were mediated, at least in part, by TGF-Ī² in the brain
Optical coherence tomography findings as a predictor of clinical course in patients with branch retinal vein occlusion treated with ranibizumab
<div><p>Purpose</p><p>To examine the relationship between optical coherence tomography (OCT) images and clinical course in eyes with branch retinal vein occlusion (BRVO) treated with intravitreal ranibizumab injection (IVR).</p><p>Design</p><p>Prospective cohort study.</p><p>Participants</p><p>Thirty eyes of 30 patients with BRVO treated with IVR.</p><p>Methods</p><p>All patients received 1 initial IVR followed by repeated injections in the pro re nata (PRN) regimen. Correlations between logarithm of minimum angle of resolution best-corrected visual acuity (logMAR BCVA) or number of IVRs after 12 months and OCT parameters including the external limiting membrane (ELM), ellipsoid zone (EZ), interdigitation zone (IZ), and photoreceptor outer segment (PROS) length at first resolution of macular edema (ME) were assessed. Resolution of ME was defined as central foveal thickness <300 Ī¼m and the absence of subretinal fluid. OCT parameters influencing BCVA and number of IVRs were evaluated using multivariate analysis. Correlations between nonperfusion areas (NPAs) and thinning areas and changes in retinal thickness of BRVO-affected areas were assessed.</p><p>Results</p><p>Of the 30 patients, 27 completed this study and were included in the statistical analyses. The mean logMAR BCVA at 3, 6, and 12 months was 0.16 Ā± 0.19, 0.09 Ā± 0.20, and 0.07 Ā± 0.20, respectively, which improved significantly from baseline at each visit (p < 0.0001, respectively), while the mean number of IVRs at 12 months was 3.9 Ā± 2.2. The mean number of IVRs for the first resolution of ME was 1.6 Ā± 0.8. Eyes with ELM and EZ defects at the points of first resolution of ME were correlated with a significantly lower BCVA at 12 months compared with eyes with preserved ELMs and EZs (p = 0.035, p = 0.002, respectively). However, eyes with IZ defects at the points of first resolution of ME were not correlated with a significantly lower BCVA at 12 months compared with eyes with preserved IZs (p = 0.160). Defects in the EZ at the points of first resolution of ME significantly affected the number of IVRs at 12 months (p = 0.042), although the ELM and IZ did not. PROS length at the points of first resolution of ME was significantly correlated with BCVA and number of IVRs at 12 months (p = 0.006, p = 0.0008, respectively). In multivariate analysis, PROS length at the points of first resolution of ME had the most significant effect on BCVA and number of IVRs (p = 0.013, p = 0.012, respectively). NPA size on fluorescein angiography and thinning area on OCT within the macular area showed a significant correlation (p = 0.003, r = 0.971). The retinal thickness of ischemic BRVO-affected areas was significantly less than that of control areas at 10, 11, and 12 months (p = 0.001, p = 0.005, p = 0.003, respectively).</p><p>Conclusion</p><p>We showed that the 1+PRN regimen may be a useful therapy for ME due to BRVO. In addition, PROS length at points of first resolution of ME appears to be a good indicator of BCVA and number of IVRs in BRVO patients.</p></div